Quick Summary
Gastric Botox (gastric botulinum toxin injection) is a non-surgical weight-loss method in which 200–300 IU of botulinum toxin is injected endoscopically into the antrum and fundus of the stomach to slow gastric contractions, delay gastric emptying, and extend the feeling of fullness. The procedure takes 15–20 minutes, its effect lasts 4–6 months, and with appropriate patient selection a weight loss of 5–15 kg can be achieved.
What Is Gastric Botox?
Gastric Botox is a non-surgical obesity treatment method in which botulinum toxin type A is injected endoscopically into the muscular layer of the stomach wall to slow gastric motility, extend satiety, and reduce appetite. It is estimated that more than 500,000 gastric Botox procedures are performed worldwide each year.
Gastric Motility Mechanism
Understanding the mechanism requires knowledge of how gastric motility works:
- Normal process: Food remains in the stomach for 2–4 hours. The stomach muscles (particularly the antrum) contract rhythmically, breaking food into smaller pieces and propelling it into the duodenum.
- Role of acetylcholine: Gastric muscle contractions are triggered by acetylcholine neurotransmitter released from nerve endings.
- Botox effect: Botulinum toxin blocks acetylcholine release, slowing gastric contractions by 40–60%.
- Result: Slowed gastric emptying keeps food in the stomach for 4–8 hours, creating prolonged satiety.
Antrum vs Fundus Injection
Gastric Botox is injected into two distinct regions — the antrum and fundus. The antrum slows gastric contractions while the fundus suppresses ghrelin secretion to reduce appetite. This dual approach is known as "anatomic gastric Botox."
| Region | Anatomical Location | Mechanism | Dose (IU) | Injection Points |
|---|---|---|---|---|
| Antrum | Lower stomach (outlet region) | Slows gastric emptying, extends satiety | 100–200 IU | 8–12 points, circumferential |
| Fundus | Upper stomach (dome region) | Reduces ghrelin secretion, suppresses appetite | 50–100 IU | 4–8 points |
| Pylorus | Gastric outlet (sphincter) | Slows gastro-intestinal transit | 50 IU (optional) | 2–4 points |
Ghrelin Hormone Suppression Mechanism
Ghrelin is a peptide hormone secreted by endocrine cells in the fundus of the stomach and known as the "hunger hormone." When gastric Botox is applied to the fundus region, it affects the muscles surrounding ghrelin-secreting cells and may indirectly reduce hormone secretion.
The effects of ghrelin in the body:
- Appetite stimulation: Activates the hypothalamic feeding centre, creating a sense of hunger
- Fat storage: Promotes energy storage
- Growth hormone: Stimulates GH release
- Reward mechanism: Activates brain reward centres, creating cravings for high-calorie foods
Bariatric surgery has been reported to reduce ghrelin levels by 40–70%. While the effect of gastric Botox on ghrelin has not yet been definitively proven in clinical studies, the fact that 94.8% of patients report reduced appetite suggests an indirect ghrelin-suppressing effect.
How Is It Performed? Endoscopic Procedure Details
Gastric Botox is performed under sedation using an endoscope (flexible camera) to access the stomach wall, where botulinum toxin is injected into the gastric muscles through a specialised injection needle. The procedure takes approximately 15–20 minutes and does not require hospitalisation — patients are discharged the same day.
Step-by-Step Procedure
- Pre-procedure preparation (1 day before): No food for the last 12 hours, no liquids for the last 6 hours. Blood-thinning medications are temporarily stopped with physician approval. Blood tests are checked.
- Anaesthesia options: Conscious sedation (IV propofol/midazolam) is the most common choice (85% of cases). General anaesthesia is rarely required.
- Endoscopy and injection (15–20 min): The endoscope is advanced from the mouth into the stomach. The gastric mucosa is visually assessed. A specialised sclerotherapy needle is passed through the endoscope working channel. Botulinum toxin is injected intraparietal (into the muscular layer of the stomach wall) at 8–12 circumferential points in the antrum and 4–8 points in the fundus. Total dose: 200–300 IU.
- Post-procedure (1–2 hours): Observation in recovery for 1–2 hours. Discharge once sedation wears off. Liquid diet for the first 6 hours, then soft foods.
Botox Dosing: 200–300 IU Evidence Base
According to clinical studies, the most commonly used dose range for gastric Botox is 200–300 IU. In a study of 500 patients, 94.8% reported reduced appetite and 92.4% achieved more than 10% weight loss with this dose range. Dose selection is individualised based on the patient's weight, BMI, and treatment goals.
| Dose (IU) | Patient Profile | Expected Weight Loss | Duration of Effect |
|---|---|---|---|
| 200 IU | BMI 30–35, first application | 5–10 kg | 4–6 months |
| 250 IU | BMI 35–38 | 8–12 kg | 4–6 months |
| 300 IU | BMI 38–40, repeat application | 10–15 kg | 5–6 months |
Important: There is no strong evidence that doses above 300 IU provide additional weight loss. Excessive dosing increases the risk of gastroparesis (excessively slow gastric emptying).
Gastric Emptying Scintigraphy Data
Gastric emptying scintigraphy is a nuclear medicine test that measures how quickly the stomach empties after consuming a radiolabelled meal. Scintigraphy data have demonstrated a 30–50% prolongation in gastric emptying time after gastric Botox.
Scintigraphy Findings
| Parameter | Before Botox | After Botox | Change |
|---|---|---|---|
| Half-emptying time (T½) | 60–90 minutes | 90–150 minutes | 50–67% increase |
| Residual at 2 hours | 30–40% | 50–70% | 50–75% increase |
| Residual at 4 hours | 5–10% | 15–30% | 100–200% increase |
These findings confirm that gastric Botox measurably slows gastric emptying. However, some meta-analyses have noted that antral Botox injection delays gastric emptying but this does not always correlate with significant weight loss — underscoring the critical role of patient selection and an accompanying dietary programme.
How Much Weight Will I Lose? 6-Month Weight-Loss Timeline
The weight-loss process after gastric Botox generally begins within the first 2 weeks, with the most intensive loss occurring in months 2–3, and a total weight loss of 5–15 kg expected by the end of month 6. These results depend on adherence to a dietary programme and physical activity.
Monthly Weight-Loss Timeline
| Period | Expected Weight Loss | Hunger Level | Notes |
|---|---|---|---|
| Week 1 | 0–1 kg | Markedly reduced | Liquid-soft diet phase |
| Weeks 2–4 | 2–4 kg | Strong suppression | Most intensive effect period |
| Months 1–2 | 4–7 kg | Stable suppression | Dietary programme is critical |
| Months 2–3 | 6–10 kg | Gradually reducing | Exercise programme should begin |
| Months 3–4 | 8–12 kg | Mild suppression | Portion control becomes important |
| Months 5–6 | 10–15 kg | Minimal effect | New habits should be established |
Realistic expectation: Gastric Botox alone is not a "miracle" weight-loss method. Without a dietary programme and exercise, average weight loss may be limited to 3–5 kg. With a dietitian-supervised programme this figure rises to 10–15 kg.
Gastric Botox vs Gastric Balloon
Gastric Botox slows gastric contractions to extend satiety, while a gastric balloon physically reduces gastric volume to limit food intake. Both methods are non-surgical, but their mechanisms, duration, and ideal patient profiles differ.
| Criterion | Gastric Botox | Gastric Balloon |
|---|---|---|
| Mechanism | Slows muscle contractions | Physically reduces volume |
| Procedure time | 15–20 min | 20–30 min |
| Anaesthesia | Sedation | Sedation |
| Duration of effect | 4–6 months | 6–12 months (removal required) |
| Weight loss | 5–15 kg | 10–20 kg |
| Nausea risk | Low (5–10%) | High (30–50%, first week) |
| Repeat | Possible | Limited |
| BMI range | 30–40 | 30–45 |
Gastric Botox vs Sleeve Gastrectomy
Gastric Botox is a reversible, non-surgical procedure, whereas sleeve gastrectomy is a permanent operation in which 80% of the stomach is surgically removed. Gastric Botox is recommended for patients with a BMI of 30–40, while sleeve gastrectomy is indicated for morbid obesity with a BMI of 40 or above.
| Criterion | Gastric Botox | Sleeve Gastrectomy |
|---|---|---|
| Procedure type | Non-surgical (endoscopic) | Surgical (laparoscopic) |
| Hospitalisation | None (day procedure) | 2–4 days |
| Recovery | 1–2 days | 2–4 weeks |
| Weight loss | 5–15 kg (5–15% body weight) | 25–40 kg (60–70% excess weight) |
| Reversibility | Fully reversible | Permanent, irreversible |
| Complication risk | Very low (1–2%) | Moderate (5–10%) |
| Ideal BMI | 30–40 | 40+ or 35+ (with comorbidities) |
Patient Selection Criteria (BMI 30–40)
The ideal candidate for gastric Botox is an individual with a BMI of 30–40 who has been unable to lose sufficient weight through diet and exercise and who does not want or is not suitable for surgical intervention. Correct patient selection determines 60% of treatment success.
Ideal Patient Criteria
- BMI 30–40 (obesity class I–III, excluding morbid obesity)
- Unable to achieve adequate weight loss through diet and exercise for at least 6 months
- Does not want or is not suitable for surgical intervention
- Willing to change emotional eating behaviour
- Sufficiently motivated to adhere to a dietary programme
- Free from chronic gastric disease (active ulcer, gastritis)
Unsuitable Patients
- BMI below 30 — unnecessary intervention
- BMI above 40 — surgery is more effective
- Active gastric ulcer or erosive gastritis
- Pregnancy or breastfeeding
- Neuromuscular diseases (myasthenia gravis, ALS)
- History of botulinum toxin allergy
Metabolic Syndrome Improvement Data
Weight loss after gastric Botox can improve metabolic syndrome components (blood sugar, blood pressure, cholesterol, triglycerides). Clinical data support that a 5–10% weight reduction improves metabolic risk parameters by 15–30%.
Changes in Metabolic Parameters
| Parameter | Improvement Rate | Explanation |
|---|---|---|
| Fasting blood sugar | 10–20% reduction | Insulin resistance decreases |
| HbA1c | 0.5–1 point reduction | Diabetes risk decreases |
| Systolic blood pressure | 5–10 mmHg reduction | Cardiovascular risk decreases |
| Triglycerides | 15–25% reduction | Fat metabolism improves |
| HDL cholesterol | 5–10% increase | "Good" cholesterol increases |
| Waist circumference | 5–10 cm reduction | Visceral fat decreases |
Combination with GLP-1 Agonists
GLP-1 receptor agonists (such as semaglutide and liraglutide) may create a synergistic effect when used alongside gastric Botox. Botox slows gastric emptying while GLP-1 agonists provide central appetite suppression and insulin regulation. This combination has not yet been confirmed by large randomised controlled trials, but clinical observations are promising.
GLP-1 Agonist Mechanism
- Glucose-dependent insulin secretion: Increases insulin release when blood glucose is elevated
- Glucagon suppression: Reduces glucagon, which raises blood sugar
- Gastric emptying delay: Slows gastric emptying (synergistic with Botox)
- Central appetite suppression: Creates satiety signals in the brain's feeding centre
- Weight loss: Clinical trials have shown 15–20% body weight loss
Combination Approach
| Period | Treatment | Goal |
|---|---|---|
| Months 1–6 | Gastric Botox + dietary programme | Initiate initial weight loss |
| Months 3–12 | Add GLP-1 agonist (if indicated) | Sustain weight loss |
| 6+ months | GLP-1 agonist + exercise + behavioural therapy | Permanent lifestyle change |
Important: GLP-1 agonists are prescription medications that require evaluation by an endocrinologist or internal medicine specialist. They are not appropriate for every patient.
Psychological Eating Behaviour Change
Although gastric Botox physically reduces appetite, lasting weight control cannot be achieved without addressing emotional eating, stress eating, and compulsive eating behaviours. Research shows that patients who receive behavioural therapy lose 35–40% more weight.
Steps for Changing Eating Behaviour
- Emotional eating awareness: Learning to distinguish between physical hunger and emotional need
- Mindful eating: Eating slowly, chewing each bite 20–30 times
- Trigger identification: Recognising emotional triggers such as stress, boredom, and sadness
- Alternative coping: Developing alternatives to eating — walking, breathing exercises, hobbies
- Professional support: Working with a psychologist or dietitian when needed
Dietary Programme
A gradual dietary transition is followed for the first 2 weeks after gastric Botox, after which a long-term nutritional programme based on calorie control, macronutrient balance, and portion management is initiated. An individualised programme prepared with a dietitian increases treatment success by 40–60%.
First 2-Week Transition Diet
| Day | Diet Type | Examples |
|---|---|---|
| Days 1–3 | Clear liquids | Water, herbal tea, clear broth |
| Days 4–7 | Full liquids | Soup, yoghurt, protein shake |
| Days 8–10 | Puréed foods | Mashed vegetables, custard |
| Days 11–14 | Soft foods | Steamed vegetables, eggs, fish |
| Day 15+ | Normal eating | With controlled portions |
Long-Term Nutritional Principles
- Daily calories: 1,200–1,500 kcal (women), 1,500–1,800 kcal (men)
- Protein: 1.2–1.5 g/kg/day — critical for muscle preservation
- Carbohydrates: Low glycaemic index, whole-grain based
- Fat: Healthy fats (olive oil, avocado, walnuts) — 25–30% of daily calories
- Fibre: 25–35 g/day — supports satiety
- Water: 2–2.5 litres/day — supports metabolism
Exercise Programme
Combining regular exercise with gastric Botox increases weight loss by 30–50%, prevents muscle loss, and preserves metabolic rate. At least 150 minutes of moderate-intensity aerobic exercise and 2 days of resistance exercise per week are recommended.
Weekly Exercise Plan
| Day | Exercise Type | Duration | Intensity |
|---|---|---|---|
| Monday | Brisk walk | 30–45 min | Moderate |
| Tuesday | Resistance training (upper body) | 30 min | Moderate |
| Wednesday | Swimming or cycling | 30–45 min | Moderate |
| Thursday | Rest or yoga | 30 min | Light |
| Friday | Resistance training (lower body) | 30 min | Moderate |
| Saturday | Nature walk or dance | 45–60 min | Moderate–high |
| Sunday | Rest | — | — |
The Importance of Nutritional Counselling
Nutritional counselling (dietitian support) is the most critical factor for the success of gastric Botox. Clinical data show that patients following a dietitian-supervised programme lose 40–60% more weight. Gastric Botox is only a "tool"; lasting results are only possible through a change in eating habits.
Advantages of Dietitian Support
| Parameter | With Dietitian | Without Dietitian |
|---|---|---|
| 6-month weight loss | 10–15 kg | 3–5 kg |
| Sustained weight control (1 year) | Successful in 70% of patients | Successful in 25% of patients |
| Muscle preservation | Protein intake optimised | Risk of muscle loss |
| Nutritional deficiency | Minimal | Occurs in 30% of patients |
| Patient satisfaction | 85%+ | 50% |
Post-Procedure Considerations
A gradual dietary transition, adequate fluid intake, and physical activity restriction should be followed in the first week after gastric Botox, while maintaining regular communication with the physician and dietitian.
First 48 Hours
- No food other than clear liquids
- No alcohol or caffeine
- No strenuous physical activity
- No pressure on the abdominal region
- Take prescribed proton pump inhibitor regularly
First Week
- Progress gradually through a liquid-to-soft diet
- Eat in small portions, frequently
- Avoid spicy and acidic foods
- No carbonated beverages
- Light walking is fine; heavy exercise should be postponed
First Month
- Gradual return to normal eating
- Develop the habit of portion control
- Weekly dietitian check-in is recommended
- Begin an exercise programme
- Water intake: 2–2.5 litres/day
Duration of Effect and Repeat Application
The effect of gastric Botox lasts 4–6 months, after which gastric contractions return to their normal rate as the botulinum toxin effect naturally wears off. Repeat application can be performed 6 months after the first dose.
Repeat Application Guide
| Session | Timing | Dose | Expected Additional Weight Loss |
|---|---|---|---|
| 1st application | Start | 200–300 IU | 5–15 kg |
| 2nd application | Month 6 | 200–300 IU | 3–8 kg additional |
| 3rd application | Month 12 | 200–250 IU | 2–5 kg additional |
Important: Additional benefit generally diminishes after the third application. The goal is to develop a lasting lifestyle change during the period of Botox effect.
Side Effects
The most common side effects of gastric Botox are mild nausea (5–10%), temporary abdominal pain (10–15%), and bloating (15–20%). These generally resolve on their own within 2–5 days. Serious complications are extremely rare (under 0.1%).
| Side Effect | Frequency | Duration | Management |
|---|---|---|---|
| Mild nausea | 5–10% | 1–3 days | Antiemetic medication |
| Abdominal pain | 10–15% | 2–5 days | Pain relief |
| Bloating | 15–20% | 3–7 days | Dietary adjustment |
| Temporary reflux | 5–8% | 1–2 weeks | Proton pump inhibitor |
| Sore throat | 5–10% | 1–2 days | Endoscope-related, self-limiting |
Contraindications
Gastric Botox is contraindicated in active peptic ulcer, pregnancy/breastfeeding, neuromuscular diseases (myasthenia gravis), botulinum toxin allergy, and gastroparesis (gastric motility disorder).
- Active peptic ulcer or erosive gastritis
- Pregnancy and breastfeeding
- Neuromuscular diseases (myasthenia gravis, Lambert-Eaton syndrome)
- History of botulinum toxin allergy
- Gastroparesis (pre-existing gastric motility disorder)
- Suspected or confirmed gastric cancer
- Active gastrointestinal bleeding
- Use of aminoglycoside antibiotics (increases Botox effect)
Anaesthesia Options and Patient Comfort
Conscious sedation (IV propofol/midazolam) is preferred in 85% of gastric Botox procedures. The patient sleeps and feels no pain, though respiratory support is rarely required. The choice of anaesthesia depends on the patient's general health, anxiety level, and physician preference.
Comparison of Anaesthesia Methods
| Method | Patient Comfort | Risk | Recovery Time | Suitable For |
|---|---|---|---|---|
| Conscious sedation | High (95% comfort) | Low | 1–2 hours | Standard patients (85%) |
| General anaesthesia | Very high (100% comfort) | Moderate | 2–4 hours | High anxiety, comorbidities |
| Topical (throat spray) | Low–moderate (60% comfort) | Very low | 15–30 min | Patients refusing sedation |
Insurance Coverage
Gastric Botox is considered an aesthetic/cosmetic procedure and is generally not covered by health insurance plans. Some private health insurers may consider coverage under obesity treatment — we recommend checking with your insurance provider. Please contact us for pricing.
Success Rates and Level of Evidence
In large observational studies, more than 10% weight loss was reported in 92.4% of patients after gastric Botox. However, some randomised controlled trials have not found a statistically significant difference compared to placebo. This highlights the determining role of patient selection and an accompanying dietary programme.
| Study Type | Result | Note |
|---|---|---|
| Observational (500 patients) | 92.4% achieved >10% weight loss | With dietary programme |
| RCT meta-analysis | Superiority over placebo not proven | Heterogeneous patient selection |
| Clinical practice data | Average 8–12 kg (6 months) | With dietitian support |
Conclusion: Gastric Botox achieves the best results with the right patient selection + dietary programme + exercise + behavioural change. It should not be seen as a "magic solution" in isolation.
Factors Affecting Success
| Factor | Impact | Explanation |
|---|---|---|
| Adherence to dietary programme | 40–50% | Most determining factor; plan with dietitian |
| Regular exercise | 20–25% | 150+ min of moderate activity per week |
| Psychological readiness | 15–20% | Awareness of emotional eating behaviour |
| Correct dose selection | 10–15% | 200–300 IU appropriate for patient's BMI |
| Injection technique | 5–10% | Anatomic antrum + fundus approach |
Pricing
Gastric Botox pricing depends on the dose used (200–300 IU), the botulinum toxin brand, and the level of the clinic. Please contact us for current pricing information. Package options including dietitian support and follow-up programmes are available.
Frequently Asked Questions (FAQ)
1. Is gastric Botox permanent?
No. The effect of botulinum toxin lasts 4–6 months, after which gastric contractions return to their normal rate. Changing dietary habits during this period is critical for lasting weight control.
2. Is gastric Botox painful?
Gastric Botox is performed under sedation, so no pain is felt during the procedure. Mild abdominal discomfort and bloating may occur for 2–5 days afterwards. 85% of patients rate the procedure as "easier than expected."
3. How much weight can I lose with gastric Botox?
When combined with a dietary programme and exercise, 5–15 kg weight loss within 6 months is expected. With gastric Botox alone, weight loss may be limited to 3–5 kg. The most intensive loss occurs in the first 2–3 months.
4. Who is gastric Botox suitable for?
It is suitable for individuals with a BMI of 30–40 who have been unable to lose sufficient weight through diet and exercise and who do not want or are not suitable for surgery.
5. What is the difference between antrum and fundus injection?
Antrum injection slows gastric contractions, delaying emptying and extending satiety. Fundus injection affects ghrelin-secreting cells to indirectly suppress appetite. Modern "anatomic gastric Botox" involves injecting both regions together.
6. What can I eat after gastric Botox?
Days 1–3: clear liquids; days 4–7: full liquids; days 8–14: soft foods; from day 15: normal eating with controlled portions.
7. Can gastric Botox and GLP-1 medications be used together?
Both work through different mechanisms and may create a synergistic effect. This combination has not yet been confirmed by large trials. GLP-1 medications require specialist prescription.
8. What is the difference between gastric Botox and a gastric balloon?
Botox slows muscle contractions; a balloon physically reduces volume. Botox takes 15–20 min with same-day discharge. Nausea affects 30–50% of balloon patients in the first week. Botox lasts 4–6 months; a balloon lasts 6–12 months.
9. When can I exercise after gastric Botox?
Rest for 24–48 hours after the procedure. Light walking from day 3; moderate exercise from week 1. Heavy lifting and intense abdominal exercises should wait 2 weeks.
10. Can gastric Botox be repeated?
Yes, it can be repeated 6 months after the first application. The second application generally provides an additional 3–8 kg weight loss. Additional benefit diminishes after a third application.
11. Can gastric Botox be performed in diabetic patients?
Patients with type 2 diabetes may undergo the procedure with endocrinologist approval. Weight loss may improve blood sugar control. Dose adjustment may be required in insulin-using patients.
12. Is nausea normal after gastric Botox?
Yes. Mild nausea may occur in 5–10% of patients in the first 1–3 days. It generally responds to antiemetic medication and resolves on its own.
13. Should 200 IU or 300 IU be preferred?
200 IU is generally sufficient for BMI 30–35 and first applications. 250–300 IU may be preferred for BMI 35–40 or repeat applications. No additional benefit has been demonstrated above 300 IU.
14. Can nutritional deficiencies occur after gastric Botox?
No significant deficiency is expected short-term. However, patients on low-calorie diets may need B12, vitamin D, iron, and calcium supplements. Following a dietitian-supervised programme minimises this risk.
15. When is gastric emptying scintigraphy performed?
It may be performed before the procedure to assess for pre-existing gastroparesis, or afterwards to measure efficacy. It is not routinely required and is planned when the physician considers it necessary.
Gastric Botox at Virtuana Clinic
At Virtuana Clinic, gastric Botox is performed alongside an experienced gastroenterology team. Each patient receives a BMI assessment, nutritional plan, and a 6-month follow-up programme. Please contact us for appointments and further information.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.